Zoetis

Do's and don'ts of cephalosporin use in swine

Disease

28 August 2025

7 minute read

Local communities support future agriculture leaders

SPONSOR Company News

21 February 2024

2 minute read

Zoetis Industry Support Program is committed to helping FFA chapters nationwide

Zoetis introduces Mhp Guardian – a personalized Mhp management program

SPONSOR Disease Managing disease Non-notifiable diseases

1 February 2023

3 minute read

A step-by-step approach tailored to your goals

PCV2 Sow Vaccination Recommendations

SPONSOR Disease Managing disease Treatments and prevention

30 January 2023

2 minute read

Recommendations for vaccinating gilts, sows and piglets.

Impact of MDA on immune responses to PCV2 vaccination

SPONSOR Disease Treatments and prevention Vaccination

30 January 2023

2 minute read

MDA can inhibit serological responses to PCV2 vaccination

June 2020 - January 2023

Two triggers for PCV2 in piglets: exposure & ability to resist infection

SPONSOR Disease

30 January 2023

2 minute read

Factors affecting indicance of PCV2

Research Summary: IMPROVEST® (gonadotropin releasing factor analog-diptheria toxoid conjugate) 0.2 mg/mL administration timing impacts performance outcomes in gilts

SPONSOR Herd management Production Management Feed and nutrition

31 October 2022

4 minute read

A new solution helps improve herd uniformity, closes the Gilt Gap

SPONSOR Herd management Gilt management

12 October 2022

7 minute read

Zoetis launches IMPROVEST® (gonadotropin releasing factor analog-diphtheria toxoid conjugate) 0.2 mg/mL for estrus suppression in market gilts

Vaccine trial data versus lineage: What’s the best way to predict PRRS vaccine performance?

SPONSOR Disease Notifiable diseases PRRS

29 June 2020

5 minute read

Zoetis statement on CVMP opinion relative to Suvaxyn PRRS MLV

SPONSOR Disease

23 June 2020

2 minute read

No product-specific concern identified for Suvaxyn PRRS MLV and benefit/risk balance for the product remains favourable.

12 posts 1 2 — 2 <

Zoetis

Do's and don'ts of cephalosporin use in swine

Local communities support future agriculture leaders

Zoetis introduces Mhp Guardian – a personalized Mhp management program

PCV2 Sow Vaccination Recommendations

Impact of MDA on immune responses to PCV2 vaccination

Our Partners

June 2020 - January 2023

Two triggers for PCV2 in piglets: exposure & ability to resist infection

Research Summary: IMPROVEST® (gonadotropin releasing factor analog-diptheria toxoid conjugate) 0.2 mg/mL administration timing impacts performance outcomes in gilts

A new solution helps improve herd uniformity, closes the Gilt Gap

Vaccine trial data versus lineage: What’s the best way to predict PRRS vaccine performance?

Zoetis statement on CVMP opinion relative to Suvaxyn PRRS MLV

Our Partners

How can we help you?

Zoetis

Do's and don'ts of cephalosporin use in swine

Local communities support future agriculture leaders

Zoetis introduces Mhp Guardian – a personalized Mhp management program

PCV2 Sow Vaccination Recommendations

Impact of MDA on immune responses to PCV2 vaccination

Our Partners

June 2020 - January 2023

Two triggers for PCV2 in piglets: exposure & ability to resist infection

Research Summary: IMPROVEST® (gonadotropin releasing factor analog-diptheria toxoid conjugate) 0.2 mg/mL administration timing impacts performance outcomes in gilts

A new solution helps improve herd uniformity, closes the Gilt Gap

Vaccine trial data versus lineage: What’s the best way to predict PRRS vaccine performance?

Zoetis statement on CVMP opinion relative to Suvaxyn PRRS MLV

Our Partners